Correlation Between Saudi Egyptian and Memphis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Saudi Egyptian and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Saudi Egyptian and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Saudi Egyptian Investment and Memphis Pharmaceuticals, you can compare the effects of market volatilities on Saudi Egyptian and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Saudi Egyptian with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Saudi Egyptian and Memphis Pharmaceuticals.

Diversification Opportunities for Saudi Egyptian and Memphis Pharmaceuticals

0.45

Correlation Coefficient

Saudi Egyptian  Memphis Pharmaceuticals

Very weak diversification

The 3 months correlation between Saudi and Memphis is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Saudi Egyptian Investment and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and Saudi Egyptian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Saudi Egyptian Investment are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of Saudi Egyptian i.e., Saudi Egyptian and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Saudi Egyptian and Memphis Pharmaceuticals

Assuming the 90 days trading horizon Saudi Egyptian is expected to generate 12.41 times less return on investment than Memphis Pharmaceuticals. But when comparing it to its historical volatility, Saudi Egyptian Investment is 2.86 times less risky than Memphis Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Memphis Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  3,798  in Memphis Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of  1,400  from holding Memphis Pharmaceuticals or generate 36.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Saudi Egyptian Investment  vs.  Memphis Pharmaceuticals

Saudi Egyptian Investment

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Saudi Egyptian Investment are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Saudi Egyptian is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Memphis Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Saudi Egyptian and Memphis Pharmaceuticals

The main advantage of trading using opposite Saudi Egyptian and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Saudi Egyptian position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.

The idea behind Saudi Egyptian Investment and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.